Biodegradable injectable in situ forming drug delivery systems

被引：557

作者：

Hatefi, A

Amsden, B ^{[1
]}

机构：

[1] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada

[2] Queens Univ, Dept Chem Engn, Kingston, ON K7L 3N6, Canada

来源：

JOURNAL OF CONTROLLED RELEASE | 2002年 / 80卷 / 1-3期

关键词：

drug delivery; in situ setting polymers; thermoresponsive polymers; thermoplastics; thermosets; solvent precipitation; ionotropic gelation; photocrosslinking gelation;

D O I：

10.1016/S0168-3659(02)00008-1

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

The ability to inject a drug incorporated into a polymer to a localized site and have the polymer form a semi-solid drug depot has a number of advantages. Among these advantages is ease of application and localized, prolonged drug delivery. For these reasons a large number of in situ setting polymeric delivery systems have been developed and investigated for use in delivering a wide variety of drugs. In this article we introduce the various strategies that have been used to prepare in situ setting systems. and outline their advantages and disadvantages as localized drug delivery systems. (C) 2002 Published by Elsevier Science B.V.

引用

页码：9 / 28

页数：20

共 168 条

[11]

Appel Leah, 1994, Pharmaceutical Research (New York), V11, pS217

[12]

ATRIX LABS INC, 2000, Patent No. 6143314

[13]

BAE YH, 1987, MAKROMOL CHEM-RAPID, V8, P481

[14]

*BASF, 1993, BASF PERF CHEM FDA E